Strata Critical Medical, Inc. SRTA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 311.88% | 276.90% | 251.42% | 178.49% | 61.43% |
| Total Depreciation and Amortization | 239.38% | 75.17% | 30.05% | -16.26% | -29.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -571.82% | -467.92% | -496.29% | -337.74% | -39.19% |
| Change in Net Operating Assets | -166.88% | -214.09% | -201.76% | 195.86% | -46.45% |
| Cash from Operations | -2,886.70% | -450.25% | -1,841.80% | -319.94% | 108.97% |
| Capital Expenditure | 33.72% | 62.77% | 68.91% | 53.16% | -5.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -4,445.20% | -2,883.63% | -2,883.63% | -2,822.60% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.87% | 424.47% | 363.56% | 471.42% | 175.81% |
| Cash from Investing | -96.26% | 1,532.45% | 6,965.16% | 1,227.94% | 761.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.88% | 35.04% | 14.88% | 39.69% | 0.00% |
| Repurchase of Common Stock | 16.62% | 47.22% | -53.62% | -450.61% | -671.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.90% | 45.07% | -54.75% | -478.83% | -744.29% |
| Foreign Exchange rate Adjustments | -367.83% | -745.83% | -323.75% | -1,118.18% | 293.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -236.88% | 1,082.25% | 223.59% | 109.54% | 389.76% |